Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a Next Day Disclosure Return dated 12 June 2026 detailing a share repurchase executed on the same day.
On 12 June 2026, TIGERMED repurchased 4.44 million A-shares on the Shenzhen Stock Exchange at prices ranging from RMB 38.40 to RMB 39.93 per share. The volume-weighted average repurchase price was RMB 39.54, resulting in a total cash outlay of approximately RMB 175.37 million.
Following the transaction, the company’s issued share capital outstanding (excluding treasury shares) declined by 0.61% to 722.96 million shares. Treasury shares increased from 10.51 million to 14.94 million, while the total issued share count remained unchanged at 737.90 million because the repurchased shares have not yet been cancelled.
The repurchase was conducted in accordance with relevant rules of both the Shenzhen Stock Exchange and the Hong Kong Stock Exchange, as confirmed by the company’s authorised director, Ye Xiaoping.
Comments